

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 4.01940764 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 4.01940764 |
| 3 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.82817759 |
| 4 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.82098422 |
| 5 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.80051548 |
| 6 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.79502672 |
| 7 | complement activation, alternative pathway (GO:0006957) | 3.71677074 |
| 8 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.58357647 |
| 9 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.52420942 |
| 10 | cardiac myofibril assembly (GO:0055003) | 3.47345134 |
| 11 | cellular response to epinephrine stimulus (GO:0071872) | 3.37609178 |
| 12 | myofibril assembly (GO:0030239) | 3.35491922 |
| 13 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.35346044 |
| 14 | ethanol oxidation (GO:0006069) | 3.34720814 |
| 15 | response to epinephrine (GO:0071871) | 3.32605565 |
| 16 | glucocorticoid biosynthetic process (GO:0006704) | 3.19911796 |
| 17 | muscle filament sliding (GO:0030049) | 3.16121761 |
| 18 | actin-myosin filament sliding (GO:0033275) | 3.16121761 |
| 19 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.11716468 |
| 20 | regulation of complement activation (GO:0030449) | 3.11562722 |
| 21 | regulation of protein activation cascade (GO:2000257) | 3.09339119 |
| 22 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.09221163 |
| 23 | regulation of cell communication by electrical coupling (GO:0010649) | 3.06804536 |
| 24 | regulation of actin filament-based movement (GO:1903115) | 3.06559254 |
| 25 | regulation of relaxation of muscle (GO:1901077) | 2.98725639 |
| 26 | cardiac muscle contraction (GO:0060048) | 2.93790683 |
| 27 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.90694629 |
| 28 | cGMP-mediated signaling (GO:0019934) | 2.90224015 |
| 29 | detection of calcium ion (GO:0005513) | 2.88541982 |
| 30 | regulation of sequestering of triglyceride (GO:0010889) | 2.87607045 |
| 31 | exogenous drug catabolic process (GO:0042738) | 2.86095941 |
| 32 | epoxygenase P450 pathway (GO:0019373) | 2.84530052 |
| 33 | sarcomere organization (GO:0045214) | 2.79046664 |
| 34 | extracellular matrix assembly (GO:0085029) | 2.78245491 |
| 35 | actin-mediated cell contraction (GO:0070252) | 2.73122799 |
| 36 | fatty acid transmembrane transport (GO:1902001) | 2.69087685 |
| 37 | drug catabolic process (GO:0042737) | 2.68882364 |
| 38 | striated muscle hypertrophy (GO:0014897) | 2.68454219 |
| 39 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.67466582 |
| 40 | negative regulation of protein localization to cell surface (GO:2000009) | 2.66695306 |
| 41 | cardiac muscle hypertrophy (GO:0003300) | 2.64882686 |
| 42 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.64873767 |
| 43 | regulation of lipoprotein metabolic process (GO:0050746) | 2.63761138 |
| 44 | myelination in peripheral nervous system (GO:0022011) | 2.57096490 |
| 45 | peripheral nervous system axon ensheathment (GO:0032292) | 2.57096490 |
| 46 | muscle hypertrophy (GO:0014896) | 2.55913570 |
| 47 | negative regulation of complement activation (GO:0045916) | 2.53509694 |
| 48 | cell communication by electrical coupling (GO:0010644) | 2.51928700 |
| 49 | neuronal ion channel clustering (GO:0045161) | 2.50130107 |
| 50 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.50018635 |
| 51 | negative regulation of protein activation cascade (GO:2000258) | 2.49868337 |
| 52 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.48163221 |
| 53 | omega-hydroxylase P450 pathway (GO:0097267) | 2.47257027 |
| 54 | regulation of membrane repolarization (GO:0060306) | 2.47184543 |
| 55 | regulation of striated muscle contraction (GO:0006942) | 2.46794866 |
| 56 | ethanol metabolic process (GO:0006067) | 2.46687325 |
| 57 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.46002399 |
| 58 | striated muscle contraction (GO:0006941) | 2.40966661 |
| 59 | cellular sodium ion homeostasis (GO:0006883) | 2.40700044 |
| 60 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.40217267 |
| 61 | cell communication involved in cardiac conduction (GO:0086065) | 2.40006517 |
| 62 | carnitine shuttle (GO:0006853) | 2.39768990 |
| 63 | glucocorticoid metabolic process (GO:0008211) | 2.39702032 |
| 64 | creatine metabolic process (GO:0006600) | 2.39458706 |
| 65 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.37280774 |
| 66 | actomyosin structure organization (GO:0031032) | 2.35138674 |
| 67 | response to catecholamine (GO:0071869) | 2.34922595 |
| 68 | response to monoamine (GO:0071867) | 2.34922595 |
| 69 | regulation of the force of heart contraction (GO:0002026) | 2.33994039 |
| 70 | glomerular basement membrane development (GO:0032836) | 2.33991419 |
| 71 | regulation of skeletal muscle contraction (GO:0014819) | 2.33149853 |
| 72 | toxin metabolic process (GO:0009404) | 2.30385877 |
| 73 | cellular response to monoamine stimulus (GO:0071868) | 2.30157719 |
| 74 | cellular response to catecholamine stimulus (GO:0071870) | 2.30157719 |
| 75 | response to methylmercury (GO:0051597) | 2.29403359 |
| 76 | regulation of cardiac muscle contraction (GO:0055117) | 2.25708298 |
| 77 | relaxation of cardiac muscle (GO:0055119) | 2.25686602 |
| 78 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.24114788 |
| 79 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.23876811 |
| 80 | cyclic nucleotide catabolic process (GO:0009214) | 2.23165968 |
| 81 | cellular response to growth hormone stimulus (GO:0071378) | 2.22391290 |
| 82 | complement activation (GO:0006956) | 2.22239867 |
| 83 | astrocyte development (GO:0014002) | 2.22126923 |
| 84 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.17353488 |
| 85 | blood coagulation, intrinsic pathway (GO:0007597) | 2.16886007 |
| 86 | protein activation cascade (GO:0072376) | 2.15575480 |
| 87 | cellular response to dexamethasone stimulus (GO:0071549) | 2.15505218 |
| 88 | drug metabolic process (GO:0017144) | 2.14729914 |
| 89 | cGMP metabolic process (GO:0046068) | 2.14272960 |
| 90 | glomerular filtration (GO:0003094) | 2.13836999 |
| 91 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.13805420 |
| 92 | L-phenylalanine catabolic process (GO:0006559) | 2.13805420 |
| 93 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.12334903 |
| 94 | positive regulation of muscle hypertrophy (GO:0014742) | 2.12334903 |
| 95 | bile acid biosynthetic process (GO:0006699) | 2.11716652 |
| 96 | membrane depolarization during action potential (GO:0086010) | 2.11163025 |
| 97 | regulation of female receptivity (GO:0045924) | 2.10952396 |
| 98 | complement activation, classical pathway (GO:0006958) | 2.10272937 |
| 99 | acylglycerol homeostasis (GO:0055090) | 2.09680987 |
| 100 | triglyceride homeostasis (GO:0070328) | 2.09680987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.52653721 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.90888890 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.08688108 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.07891555 |
| 5 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07317664 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.02136244 |
| 7 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.01856470 |
| 8 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.99446015 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.95875460 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.87010230 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.80733622 |
| 12 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.79603942 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.78967790 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72404306 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.71848026 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.70087542 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.68253396 |
| 18 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.65977738 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.65736259 |
| 20 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.65591724 |
| 21 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.65233807 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.61310656 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.61310656 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.58579344 |
| 25 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.54687997 |
| 26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52282946 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.50797051 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.50648511 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50335426 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.46667187 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.46304035 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.45664059 |
| 33 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45635892 |
| 34 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.45062204 |
| 35 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44131467 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.44070312 |
| 37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43140292 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.41227154 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.40737263 |
| 40 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38961000 |
| 41 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.37110606 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.36193557 |
| 43 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.32283644 |
| 44 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.32283644 |
| 45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30654688 |
| 46 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.30493292 |
| 47 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27742294 |
| 48 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27529239 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27509902 |
| 50 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26917724 |
| 51 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.25458619 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23070400 |
| 53 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22804852 |
| 54 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.20512347 |
| 55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20499080 |
| 56 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19643472 |
| 57 | TCF4_23295773_ChIP-Seq_U87_Human | 1.19629961 |
| 58 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18817900 |
| 59 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17910946 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17704099 |
| 61 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17358636 |
| 62 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17038167 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15736547 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14280999 |
| 65 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14211945 |
| 66 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12642662 |
| 67 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11950231 |
| 68 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11385464 |
| 69 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11140239 |
| 70 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10335827 |
| 71 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09902282 |
| 72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08533105 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06040628 |
| 74 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05998922 |
| 75 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05998922 |
| 76 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05507478 |
| 77 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03685428 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02662922 |
| 79 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02498344 |
| 80 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02348584 |
| 81 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02316393 |
| 82 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02088319 |
| 83 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02088319 |
| 84 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01905235 |
| 85 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00635193 |
| 86 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00582981 |
| 87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00410814 |
| 88 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.00397536 |
| 89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98979539 |
| 90 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98936693 |
| 91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98303928 |
| 92 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97953822 |
| 93 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97355724 |
| 94 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97109527 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97009494 |
| 96 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96791786 |
| 97 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.96427785 |
| 98 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96237562 |
| 99 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96204168 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95195581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005503_abnormal_tendon_morphology | 3.50529341 |
| 2 | MP0000751_myopathy | 3.44240206 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.30588796 |
| 4 | MP0005275_abnormal_skin_tensile | 3.17466416 |
| 5 | MP0005670_abnormal_white_adipose | 3.15531271 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.14455132 |
| 7 | MP0004215_abnormal_myocardial_fiber | 2.62638946 |
| 8 | MP0004036_abnormal_muscle_relaxation | 2.58811550 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.45223280 |
| 10 | MP0010368_abnormal_lymphatic_system | 2.42503066 |
| 11 | MP0004130_abnormal_muscle_cell | 2.31975892 |
| 12 | MP0003646_muscle_fatigue | 2.31607170 |
| 13 | MP0001958_emphysema | 2.23338749 |
| 14 | MP0000749_muscle_degeneration | 2.11692208 |
| 15 | MP0002108_abnormal_muscle_morphology | 2.09889515 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.05031640 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.01117236 |
| 18 | MP0001661_extended_life_span | 1.79451886 |
| 19 | MP0008775_abnormal_heart_ventricle | 1.75789479 |
| 20 | MP0006138_congestive_heart_failure | 1.73824638 |
| 21 | MP0003690_abnormal_glial_cell | 1.73251841 |
| 22 | MP0005620_abnormal_muscle_contractility | 1.65004439 |
| 23 | MP0004272_abnormal_basement_membrane | 1.62113968 |
| 24 | MP0002638_abnormal_pupillary_reflex | 1.60927688 |
| 25 | MP0005330_cardiomyopathy | 1.56145158 |
| 26 | MP0004087_abnormal_muscle_fiber | 1.52541534 |
| 27 | MP0002295_abnormal_pulmonary_circulatio | 1.49248620 |
| 28 | MP0002971_abnormal_brown_adipose | 1.46791607 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.46409682 |
| 30 | MP0000747_muscle_weakness | 1.43371160 |
| 31 | MP0003279_aneurysm | 1.41748418 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.41658292 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.36956559 |
| 34 | MP0004484_altered_response_of | 1.35854052 |
| 35 | MP0005369_muscle_phenotype | 1.35380545 |
| 36 | MP0005595_abnormal_vascular_smooth | 1.34915732 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.34224280 |
| 38 | MP0001486_abnormal_startle_reflex | 1.33679626 |
| 39 | MP0000013_abnormal_adipose_tissue | 1.33265859 |
| 40 | MP0003137_abnormal_impulse_conducting | 1.32836511 |
| 41 | MP0001984_abnormal_olfaction | 1.32736252 |
| 42 | MP0005385_cardiovascular_system_phenoty | 1.32595739 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 1.32595739 |
| 44 | MP0000920_abnormal_myelination | 1.30955540 |
| 45 | MP0004085_abnormal_heartbeat | 1.28262835 |
| 46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.25188297 |
| 47 | MP0002269_muscular_atrophy | 1.23621226 |
| 48 | MP0003011_delayed_dark_adaptation | 1.22163120 |
| 49 | MP0002272_abnormal_nervous_system | 1.21807921 |
| 50 | MP0005171_absent_coat_pigmentation | 1.21017253 |
| 51 | MP0010329_abnormal_lipoprotein_level | 1.20927403 |
| 52 | MP0002106_abnormal_muscle_physiology | 1.20066586 |
| 53 | MP0005666_abnormal_adipose_tissue | 1.19802688 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.12301925 |
| 55 | MP0005365_abnormal_bile_salt | 1.11350826 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.09560037 |
| 57 | MP0002064_seizures | 1.05215185 |
| 58 | MP0000759_abnormal_skeletal_muscle | 1.04505745 |
| 59 | MP0004270_analgesia | 1.04227354 |
| 60 | MP0001299_abnormal_eye_distance/ | 1.04052344 |
| 61 | MP0001879_abnormal_lymphatic_vessel | 1.03518352 |
| 62 | MP0000230_abnormal_systemic_arterial | 1.03045549 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.02770827 |
| 64 | MP0005375_adipose_tissue_phenotype | 1.01950654 |
| 65 | MP0000566_synostosis | 1.01130603 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.00173437 |
| 67 | MP0001502_abnormal_circadian_rhythm | 0.96437493 |
| 68 | MP0003868_abnormal_feces_composition | 0.94621661 |
| 69 | MP0002127_abnormal_cardiovascular_syste | 0.93751668 |
| 70 | MP0009745_abnormal_behavioral_response | 0.93164353 |
| 71 | MP0004885_abnormal_endolymph | 0.92165741 |
| 72 | MP0000750_abnormal_muscle_regeneration | 0.90808561 |
| 73 | MP0002139_abnormal_hepatobiliary_system | 0.90325932 |
| 74 | MP0005423_abnormal_somatic_nervous | 0.89451227 |
| 75 | MP0003879_abnormal_hair_cell | 0.89143187 |
| 76 | MP0003633_abnormal_nervous_system | 0.88877052 |
| 77 | MP0003045_fibrosis | 0.86473140 |
| 78 | MP0003195_calcinosis | 0.85090622 |
| 79 | MP0005508_abnormal_skeleton_morphology | 0.84532295 |
| 80 | MP0003632_abnormal_nervous_system | 0.84032683 |
| 81 | MP0010630_abnormal_cardiac_muscle | 0.83652353 |
| 82 | MP0005535_abnormal_body_temperature | 0.83469169 |
| 83 | MP0000003_abnormal_adipose_tissue | 0.83206335 |
| 84 | MP0002332_abnormal_exercise_endurance | 0.83188115 |
| 85 | MP0009046_muscle_twitch | 0.82695768 |
| 86 | MP0003635_abnormal_synaptic_transmissio | 0.81842834 |
| 87 | MP0002118_abnormal_lipid_homeostasis | 0.80596953 |
| 88 | MP0002133_abnormal_respiratory_system | 0.80175557 |
| 89 | MP0005388_respiratory_system_phenotype | 0.80175557 |
| 90 | MP0005332_abnormal_amino_acid | 0.79987010 |
| 91 | MP0009384_cardiac_valve_regurgitation | 0.78805612 |
| 92 | MP0003329_amyloid_beta_deposits | 0.77112705 |
| 93 | MP0003631_nervous_system_phenotype | 0.76548407 |
| 94 | MP0008004_abnormal_stomach_pH | 0.76086535 |
| 95 | MP0004859_abnormal_synaptic_plasticity | 0.74369125 |
| 96 | MP0000639_abnormal_adrenal_gland | 0.73839873 |
| 97 | MP0002063_abnormal_learning/memory/cond | 0.73183580 |
| 98 | MP0003136_yellow_coat_color | 0.72945956 |
| 99 | MP0002909_abnormal_adrenal_gland | 0.72886788 |
| 100 | MP0005360_urolithiasis | 0.72328585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 5.65601594 |
| 2 | Bundle branch block (HP:0011710) | 4.42756731 |
| 3 | Abnormality of complement system (HP:0005339) | 4.29868814 |
| 4 | Muscle fiber splitting (HP:0003555) | 4.20719572 |
| 5 | Sudden death (HP:0001699) | 4.14139334 |
| 6 | Type 1 muscle fiber predominance (HP:0003803) | 4.07049520 |
| 7 | Hyporeflexia of lower limbs (HP:0002600) | 3.95123773 |
| 8 | Atrial fibrillation (HP:0005110) | 3.60702127 |
| 9 | Heart block (HP:0012722) | 3.32650773 |
| 10 | Primary atrial arrhythmia (HP:0001692) | 3.29730526 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 3.24528420 |
| 12 | Syncope (HP:0001279) | 3.21002813 |
| 13 | Aortic aneurysm (HP:0004942) | 3.14987641 |
| 14 | Abnormal atrioventricular conduction (HP:0005150) | 3.12727742 |
| 15 | Supraventricular tachycardia (HP:0004755) | 3.11055847 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 3.10802091 |
| 17 | Supraventricular arrhythmia (HP:0005115) | 3.06670803 |
| 18 | Broad metatarsal (HP:0001783) | 3.04069320 |
| 19 | Lipoatrophy (HP:0100578) | 2.98458907 |
| 20 | Calf muscle hypertrophy (HP:0008981) | 2.96962590 |
| 21 | Glomerulonephritis (HP:0000099) | 2.88262114 |
| 22 | Atrioventricular block (HP:0001678) | 2.85219814 |
| 23 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.83521744 |
| 24 | Asymmetric septal hypertrophy (HP:0001670) | 2.82913438 |
| 25 | Muscle fiber inclusion bodies (HP:0100299) | 2.79675991 |
| 26 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.75438406 |
| 27 | Pulmonary artery stenosis (HP:0004415) | 2.74400118 |
| 28 | Prolonged QT interval (HP:0001657) | 2.70788751 |
| 29 | Protrusio acetabuli (HP:0003179) | 2.68530942 |
| 30 | Ventricular tachycardia (HP:0004756) | 2.68150274 |
| 31 | Nemaline bodies (HP:0003798) | 2.67301883 |
| 32 | Round ear (HP:0100830) | 2.64786853 |
| 33 | EMG: myopathic abnormalities (HP:0003458) | 2.64665973 |
| 34 | Difficulty running (HP:0009046) | 2.61475002 |
| 35 | Limited hip movement (HP:0008800) | 2.55223317 |
| 36 | Increased variability in muscle fiber diameter (HP:0003557) | 2.51540329 |
| 37 | Action tremor (HP:0002345) | 2.48679177 |
| 38 | Exercise-induced myalgia (HP:0003738) | 2.47555073 |
| 39 | Hyperlipoproteinemia (HP:0010980) | 2.46435132 |
| 40 | Vascular tortuosity (HP:0004948) | 2.46189430 |
| 41 | Nephritis (HP:0000123) | 2.43877662 |
| 42 | Oligomenorrhea (HP:0000876) | 2.41441307 |
| 43 | Increased connective tissue (HP:0009025) | 2.39756836 |
| 44 | Ventricular arrhythmia (HP:0004308) | 2.32637783 |
| 45 | Dilated cardiomyopathy (HP:0001644) | 2.32202813 |
| 46 | Myotonia (HP:0002486) | 2.32046691 |
| 47 | Aortic dissection (HP:0002647) | 2.26592414 |
| 48 | Distal arthrogryposis (HP:0005684) | 2.24502023 |
| 49 | Decreased circulating renin level (HP:0003351) | 2.23386966 |
| 50 | Mitral stenosis (HP:0001718) | 2.20108218 |
| 51 | Neck muscle weakness (HP:0000467) | 2.15621724 |
| 52 | Hypoplasia of the iris (HP:0007676) | 2.13839448 |
| 53 | Prolonged partial thromboplastin time (HP:0003645) | 2.11951223 |
| 54 | Focal motor seizures (HP:0011153) | 2.09930009 |
| 55 | Ulnar claw (HP:0001178) | 2.06987139 |
| 56 | Frequent falls (HP:0002359) | 2.06848802 |
| 57 | Hip contracture (HP:0003273) | 2.04426362 |
| 58 | Striae distensae (HP:0001065) | 2.01542345 |
| 59 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.99403377 |
| 60 | Keratoconus (HP:0000563) | 1.99004772 |
| 61 | Increased corneal curvature (HP:0100692) | 1.99004772 |
| 62 | Joint hemorrhage (HP:0005261) | 1.98806451 |
| 63 | Abnormal EKG (HP:0003115) | 1.98549463 |
| 64 | Coronal craniosynostosis (HP:0004440) | 1.98405817 |
| 65 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.97227279 |
| 66 | Abnormality of the ischium (HP:0003174) | 1.96274890 |
| 67 | Scanning speech (HP:0002168) | 1.95727516 |
| 68 | Subaortic stenosis (HP:0001682) | 1.95439466 |
| 69 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.95439466 |
| 70 | Wrist flexion contracture (HP:0001239) | 1.93427622 |
| 71 | Ventricular fibrillation (HP:0001663) | 1.91850183 |
| 72 | Bell-shaped thorax (HP:0001591) | 1.91500418 |
| 73 | Arterial tortuosity (HP:0005116) | 1.89255162 |
| 74 | Exercise-induced muscle cramps (HP:0003710) | 1.87703343 |
| 75 | Abnormality of the foot musculature (HP:0001436) | 1.87597527 |
| 76 | Skin nodule (HP:0200036) | 1.86536292 |
| 77 | Myoglobinuria (HP:0002913) | 1.85892265 |
| 78 | Steppage gait (HP:0003376) | 1.85856260 |
| 79 | Soft skin (HP:0000977) | 1.83100012 |
| 80 | Blue irides (HP:0000635) | 1.83050489 |
| 81 | Hypoalphalipoproteinemia (HP:0003233) | 1.82032909 |
| 82 | Focal seizures (HP:0007359) | 1.79491707 |
| 83 | Xanthomatosis (HP:0000991) | 1.78844692 |
| 84 | Alacrima (HP:0000522) | 1.78401518 |
| 85 | Hyperventilation (HP:0002883) | 1.78105289 |
| 86 | Absent phalangeal crease (HP:0006109) | 1.76501673 |
| 87 | Wide anterior fontanel (HP:0000260) | 1.76288317 |
| 88 | Bronchomalacia (HP:0002780) | 1.74507992 |
| 89 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.74446096 |
| 90 | Aplasia of the phalanges of the hand (HP:0009802) | 1.74446096 |
| 91 | Aplasia involving bones of the extremities (HP:0009825) | 1.74446096 |
| 92 | Foot dorsiflexor weakness (HP:0009027) | 1.74027554 |
| 93 | Spinal rigidity (HP:0003306) | 1.73133638 |
| 94 | Turricephaly (HP:0000262) | 1.72954952 |
| 95 | Shallow orbits (HP:0000586) | 1.72824606 |
| 96 | Left ventricular hypertrophy (HP:0001712) | 1.71677618 |
| 97 | Muscular dystrophy (HP:0003560) | 1.71155395 |
| 98 | Epidermoid cyst (HP:0200040) | 1.70320571 |
| 99 | Right ventricular cardiomyopathy (HP:0011663) | 1.69454552 |
| 100 | Infantile muscular hypotonia (HP:0008947) | 1.69262354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 3.72387707 |
| 2 | MYLK | 3.05373544 |
| 3 | PINK1 | 2.60712139 |
| 4 | MARK1 | 2.56087625 |
| 5 | EPHA3 | 2.45801318 |
| 6 | TIE1 | 2.38474239 |
| 7 | NTRK3 | 2.31069257 |
| 8 | FRK | 2.28135519 |
| 9 | FGFR2 | 2.08435412 |
| 10 | PHKG2 | 2.07459755 |
| 11 | PHKG1 | 2.07459755 |
| 12 | TTN | 1.84070563 |
| 13 | DDR2 | 1.73435265 |
| 14 | DMPK | 1.70024509 |
| 15 | AKT3 | 1.57142230 |
| 16 | PIK3CA | 1.53123074 |
| 17 | PKN1 | 1.50308974 |
| 18 | TGFBR2 | 1.48580939 |
| 19 | PAK3 | 1.45274766 |
| 20 | MAPK12 | 1.43831254 |
| 21 | NTRK2 | 1.37161866 |
| 22 | PRKAA2 | 1.29581169 |
| 23 | PDK2 | 1.29300159 |
| 24 | DAPK2 | 1.26142076 |
| 25 | RIPK1 | 1.24731122 |
| 26 | NEK9 | 1.24265141 |
| 27 | PDGFRA | 1.23423223 |
| 28 | NLK | 1.21421592 |
| 29 | UHMK1 | 1.20812974 |
| 30 | MAPKAPK3 | 1.18817868 |
| 31 | TNIK | 1.18458608 |
| 32 | STK38L | 1.18342463 |
| 33 | ADRBK2 | 1.18079621 |
| 34 | MAP3K7 | 1.15146744 |
| 35 | NTRK1 | 1.14826476 |
| 36 | TRPM7 | 1.14255824 |
| 37 | PIK3CG | 1.13014930 |
| 38 | PRKD1 | 1.12454840 |
| 39 | PRKCE | 1.12316689 |
| 40 | SGK223 | 1.10976345 |
| 41 | SGK494 | 1.10976345 |
| 42 | SGK2 | 1.10454390 |
| 43 | STK39 | 1.08792024 |
| 44 | CAMK2D | 1.08579626 |
| 45 | CAMK1 | 1.08231824 |
| 46 | CAMK2B | 1.07716929 |
| 47 | MAPK7 | 1.04475315 |
| 48 | MAPK13 | 1.00592637 |
| 49 | MAPK15 | 1.00290253 |
| 50 | CAMK2G | 0.98916748 |
| 51 | MUSK | 0.98478103 |
| 52 | EPHB2 | 0.98445868 |
| 53 | GRK1 | 0.95590348 |
| 54 | PAK6 | 0.94593938 |
| 55 | CAMK2A | 0.92806622 |
| 56 | PRKG1 | 0.92349595 |
| 57 | ROCK1 | 0.90812985 |
| 58 | LATS1 | 0.88519214 |
| 59 | WNK1 | 0.88005707 |
| 60 | EPHA4 | 0.83309266 |
| 61 | PDGFRB | 0.79398558 |
| 62 | ADRBK1 | 0.78066844 |
| 63 | PTK2B | 0.77568776 |
| 64 | FER | 0.76264631 |
| 65 | ROCK2 | 0.75467584 |
| 66 | GRK5 | 0.74620782 |
| 67 | CDC42BPA | 0.73518552 |
| 68 | INSRR | 0.73095583 |
| 69 | MAPKAPK5 | 0.72119416 |
| 70 | MAP3K6 | 0.72098703 |
| 71 | PRKAA1 | 0.71340133 |
| 72 | PRKACG | 0.68710987 |
| 73 | CASK | 0.68694248 |
| 74 | PRKACA | 0.67836688 |
| 75 | MAPK4 | 0.66333202 |
| 76 | MAP3K4 | 0.64525252 |
| 77 | LATS2 | 0.63340911 |
| 78 | MET | 0.63308026 |
| 79 | RPS6KA3 | 0.62952651 |
| 80 | JAK1 | 0.61968226 |
| 81 | SGK1 | 0.61651455 |
| 82 | OXSR1 | 0.61088407 |
| 83 | STK11 | 0.60416304 |
| 84 | BMPR1B | 0.60261200 |
| 85 | PRKCG | 0.60039484 |
| 86 | MAP2K1 | 0.58752176 |
| 87 | CAMK4 | 0.58467683 |
| 88 | CDK5 | 0.57953505 |
| 89 | RET | 0.57638304 |
| 90 | PAK2 | 0.56605177 |
| 91 | SGK3 | 0.55927254 |
| 92 | DAPK3 | 0.53846064 |
| 93 | PRKACB | 0.49054247 |
| 94 | TGFBR1 | 0.48878785 |
| 95 | MAPK10 | 0.48253805 |
| 96 | MARK2 | 0.45607968 |
| 97 | TYRO3 | 0.44948496 |
| 98 | MAP2K4 | 0.44187623 |
| 99 | FGFR3 | 0.44136488 |
| 100 | JAK2 | 0.43588854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Histidine metabolism_Homo sapiens_hsa00340 | 2.63423807 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.39041591 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.12061798 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.08156588 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.07881862 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06789429 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.93869367 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.87515194 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86121265 |
| 10 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78664960 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.76037580 |
| 12 | Retinol metabolism_Homo sapiens_hsa00830 | 1.75769398 |
| 13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73711856 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.73027054 |
| 15 | Bile secretion_Homo sapiens_hsa04976 | 1.69280122 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.68200052 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.62149646 |
| 18 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.58225624 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.51093695 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.47755093 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47506978 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47257749 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.47221535 |
| 24 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.45671893 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.44007676 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.43740100 |
| 27 | * ABC transporters_Homo sapiens_hsa02010 | 1.42814308 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.42647107 |
| 29 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.39089658 |
| 30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.39060799 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.35952047 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.34244257 |
| 33 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.31955676 |
| 34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.31278968 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.30048896 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.26532030 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.25688417 |
| 38 | Circadian entrainment_Homo sapiens_hsa04713 | 1.18758125 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.16212095 |
| 40 | Circadian rhythm_Homo sapiens_hsa04710 | 1.15546802 |
| 41 | Insulin secretion_Homo sapiens_hsa04911 | 1.10156014 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09317889 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 1.06440679 |
| 44 | Prion diseases_Homo sapiens_hsa05020 | 1.04035158 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.02531985 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02111060 |
| 47 | GABAergic synapse_Homo sapiens_hsa04727 | 0.96826861 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.96235659 |
| 49 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.95116260 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93175191 |
| 51 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.92526797 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92277165 |
| 53 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91310974 |
| 54 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89808843 |
| 55 | Mineral absorption_Homo sapiens_hsa04978 | 0.89023625 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88046321 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84675047 |
| 58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84293858 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82008359 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.81600442 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 0.81575377 |
| 62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80994944 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80673655 |
| 64 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.80516827 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79369218 |
| 66 | Nicotine addiction_Homo sapiens_hsa05033 | 0.78626568 |
| 67 | Peroxisome_Homo sapiens_hsa04146 | 0.76166004 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74702723 |
| 69 | Focal adhesion_Homo sapiens_hsa04510 | 0.74448987 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.73976023 |
| 71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.72121360 |
| 72 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.71511634 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.68852880 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63096814 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61493401 |
| 76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60610626 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59490961 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59034799 |
| 79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56290261 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56169048 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55487059 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 0.54636483 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54072125 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.52930637 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52779080 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52674471 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.52180979 |
| 88 | Taste transduction_Homo sapiens_hsa04742 | 0.51077631 |
| 89 | Gap junction_Homo sapiens_hsa04540 | 0.50613943 |
| 90 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.50486898 |
| 91 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50231471 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50209052 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50147708 |
| 94 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49525136 |
| 95 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49438829 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49056375 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46433644 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46360923 |
| 99 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.45322370 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45008867 |

